Clinical Trial Update: Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System

View source ↗

Summary

Post-market clinical follow-up study of the Zimmer Stafit Acetabular System has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Hip
• Dislocated Hip
• Fracture of the Hip
• Osteoarthritis of the Hip
• Osteonecrosis
• Post-traumatic Arthrosis
• Rheumatoid Arthritis
• Subluxation of the Hip

Drugs mentioned

• Stafit Acetabular System

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Hip, Fracture of Hip | Status: TERMINATED | Results posted: 2020-06-30